Advanced Search

Critical Care & Emergency Medicine Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

HEADS OF FACULTY

  • Photo of Jesse Hall

    Jesse Hall

    Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL, USA

  • Photo of Jean-Louis Vincent

    Jean-Louis Vincent

    Department of Intensive Care, Erasme University Hospital, Brussels, Belgium

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

9
Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis.

Mitaka C, Kudo T, Haraguchi G, Tomita M. Crit Care. 2011 Oct 27; 15(5):R258

2 Evaluations, most recent by

Jean-Charles Preiser, Erasme University Hospital, Belgium. F1000 Critical Care & Emergency Medicine

Past 7 Days

12

New Evaluations

5,989 total

5

New Articles Evaluated

3,088 total

Past 30 Days

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.